Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$807,489,467
-$338,889,724 QoQ
Shares Held
33,533,616
-17.9% QoQ
Ownership
0.588%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#19
of 2,812 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. PFE ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
This page
|
33,533,616 | $807,489,467 |
All Filings in PFE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $807,489,467 | 33,533,616 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,146,379,191 | 40,825,470 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,171,878,157 | 47,063,380 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,057,188,864 | 41,490,929 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $907,727,781 | 37,447,516 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,319,970,794 | 52,090,403 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $963,876,189 | 36,331,557 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,363,997,427 | 47,131,909 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,403,277,316 | 50,152,871 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,286,374,601 | 46,355,842 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,225,578,737 | 42,569,599 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,278,210,911 | 38,535,150 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,263,988,970 | 34,459,896 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,431,014,371 | 35,073,882 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,666,731,631 | 32,527,940 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,389,306,599 | 31,748,323 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,456,995,284 | 27,789,344 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $1,327,398,469 | 25,640,303 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,392,589,419 | 23,583,225 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $862,011,577 | 20,042,120 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $787,779,941 | 20,116,955 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||